IBIS PHARMA
ActiveSummary
IBIS PHARMA has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4.0m and a net result of €561,907. Equity is growing by about 3.5% per year across the filed financial years. Its solvency ranks better than 80% of 5,034 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
13-07
NBB filing
Annual accounts filed
financial year 2025 · full format
12-06
Gazette deed
Appointment: DGST & Partners - Réviseurs d'entreprises (statutory auditor)2 facts ▸
Gazette deed
Appointment: DGST & Partners - Réviseurs d'entreprises (statutory auditor)
2 facts ▸
- General meeting, 13-05-2025
- Auditor appointment, DGST & Partners - Réviseurs d'entreprises (statutory auditor)
2025
22-09
Gazette deed
Resignations: MARECHAL Philippe, DASSAS Serge and DELEGLISE Jean-PierreAppointments: MARECHAL Philippe, DASSAS Serge and DELEGLISE Jean-Pierre · Director discharge · Registered-office move18 facts ▸
Gazette deed
Resignations: MARECHAL Philippe, DASSAS Serge and DELEGLISE Jean-Pierre
Appointments: MARECHAL Philippe, DASSAS Serge and DELEGLISE Jean-Pierre · Director discharge · Registered-office move18 facts ▸
- General meeting, 09-09-2025
- Director resignation, MARECHAL Philippe (director)
- Director resignation, DASSAS Serge (director)
- Director resignation, DELEGLISE Jean-Pierre (director)
- Director discharge, MARECHAL Philippe
- Director discharge, DASSAS Serge
- Director discharge, DELEGLISE Jean-Pierre
- Director in office, MARECHAL Philippe (director)
- Director in office, DASSAS Serge (director)
- Director in office, DELEGLISE Jean-Pierre (director)
- Other provision, “ratification des décisions des administrateurs, dans la mesure où cela serait nécessaire” (deed in French)
- Director appointment, MARECHAL Philippe (director (not named in the articles))
- +6 further facts in this act
27-05
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
24-07
NBB filing
Annual accounts filed
financial year 2023 · full format
12-02
Gazette deed
End & cessationAppointment: ANDRE FRANCOIS, REVISEUR D'ENTREPRISES (réviseur d'entreprises)2 facts ▸
Gazette deed
End & cessation
Appointment: ANDRE FRANCOIS, REVISEUR D'ENTREPRISES (réviseur d'entreprises)2 facts ▸
- General meeting, 15-12-2023
- Auditor appointment, ANDRE FRANCOIS, REVISEUR D'ENTREPRISES (réviseur d'entreprises)
2023
31-12
Financial
Weakest financial yearnet €440,750 ▼34.8%
Net result drops to €440,750, the lowest in the series; recovery starts the following year.
22-05
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
04-07
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial
Highest result from 2018 to 2025net €699,918 ▲25.1%
Net result €699,918, the highest in the series.
09-06
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
09-07
NBB filing
Annual accounts filed
financial year 2019 · full format
Show earlier events
2019
27-08
NBB filing
Annual accounts filed
financial year 2018 · full format · 27 days late
2018
27-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
28-08
NBB filing
Annual accounts filed
financial year 2016 · full format · 28 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 33 annual accounts filed, the latest 10 are here; all 33 are under Financials.
3 of 7 deeds read
About the unread acts
Of the 7 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.